{"id":1063175,"date":"2012-07-29T15:48:03","date_gmt":"2012-07-29T15:48:03","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/two-more-disease-team-applications-sent-back-for-more-review\/"},"modified":"2024-08-17T20:27:36","modified_gmt":"2024-08-18T00:27:36","slug":"two-more-disease-team-applications-sent-back-for-more-review-2","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/two-more-disease-team-applications-sent-back-for-more-review-2.php","title":{"rendered":"Two More Disease Team Applications Sent Back for More Review"},"content":{"rendered":"<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/IByTlC62N14L8LLmgmSl--tRsto\/0\/da\"><img decoding=\"async\" src=\"http:\/\/www.longevitymedicine.tv\/wp-content\/plugins\/wp-o-matic\/cache\/55a04_di\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a><br><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/IByTlC62N14L8LLmgmSl--tRsto\/1\/da\"><img decoding=\"async\" src=\"http:\/\/www.longevitymedicine.tv\/wp-content\/plugins\/wp-o-matic\/cache\/55a04_di\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a><\/p><p>Directors of the California stem cell agency today referred two additional research applications for $37 million in disease team funding back to reviewers for further consideration.<\/p><p>Both were the subjects of appeals by researchers whose proposals were rejected by grant reviewers.<\/p><p><a href=\"http:\/\/cirm.ca.gov\/ReviewSummary_DR2A-05352\">One<\/a> was from&nbsp;<b>Timothy Hoey<\/b> of <b>OncoMed Pharmaceuticals<\/b> in Redwood City, who sought $20 million. &nbsp;<a href=\"http:\/\/cirm.ca.gov\/ReviewSummary_DR2A-05739\">The other<\/a> was from <b>Henry Klassen<\/b> of <b>UC Irvine<\/b>, who sought $17 million. (See <a href=\"http:\/\/cirm.ca.gov\/files\/meetings\/pdf\/2012\/072612_item_6_5352_ICOC.pdf\">here<\/a> and<a href=\"http:\/\/cirm.ca.gov\/files\/meetings\/pdf\/2012\/072612_item_6_5739_ICOC.pdf\"> here<\/a> for their appeals.)<\/p><p>The &nbsp;board began the day by directing staff to come back to the board in early September. But with the large number of grants to be reassessed, it was acknowledged some might not be acted on until the board's meeting in late October.<\/p><div><img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"http:\/\/www.longevitymedicine.tv\/wp-content\/plugins\/wp-o-matic\/cache\/55a04_10000891-5362737551790708026?l=californiastemcellreport.blogspot.com\" alt=\"\" style=\"padding-left:10px; padding-right: 10px;\"><\/div><p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/www.longevitymedicine.tv\/wp-content\/plugins\/wp-o-matic\/cache\/55a04_0OwPVZpLkTs\" height=\"1\" width=\"1\" style=\"padding-left:10px; padding-right: 10px;\">Source:<br><a href=\"http:\/\/californiastemcellreport.blogspot.com\/feeds\/posts\/default?alt=rss\">http:\/\/californiastemcellreport.blogspot.com\/feeds\/posts\/default?alt=rss<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Directors of the California stem cell agency today referred two additional research applications for $37 million in disease team funding back to reviewers for further consideration.Both were the subjects of appeals by researchers whose proposals were rejected by grant reviewers.One &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/two-more-disease-team-applications-sent-back-for-more-review-2.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25,1246878],"tags":[],"class_list":["post-1063175","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy","category-stem-cells"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063175"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1063175"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063175\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1063175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1063175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1063175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}